Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Elstar Therapeutics

Request full access

Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics

Cambridge, United StatesFounded 2015Biotech & Life Sciences

About Elstar Therapeutics

Marengo Therapeutics is a biotech startup that operates in the healthcare industry, specifically in the field of cancer treatment. The company's primary focus is on developing innovative therapies that harness the power of the body's own immune system to fight cancer. They have developed a unique therapeutic platform that selectively enhances certain subsets of a patient's T cells, transforming them into powerful cancer-fighting agents. This approach not only helps in combating the disease but also promotes long-term immunity, helping to keep cancer at bay.

The company's groundbreaking approach involves a novel method of T cell activation. The scientists at Marengo have discovered a new way to activate specific T cell subsets and combat tumors by directly targeting Variable β (Vβ) chain variants of the TCR. In simpler terms, they have found a way to "switch on" certain cells in the immune system that are particularly effective at fighting cancer.

Marengo's business model revolves around the development and commercialization of their first-in-class bispecific antibody library. This library allows for the selective activation and expansion of a wide range of different Vβ TCR variants, essentially providing a vast array of potential cancer-fighting cells ready to be activated when needed. The company generates revenue through the development, licensing, and sale of these innovative cancer therapies.

In summary, Marengo Therapeutics is a pioneering biotech startup that is revolutionizing cancer treatment by harnessing the power of the body's own immune system. Their innovative approach and unique therapeutic platform have the potential to make a significant impact in the fight against cancer.

Source: Dealroom company data

At a glance

Status
Operational
Employees
40
Open positions
1
Dealroom signal
64.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Nov 2021 $80M $320M Apple Tree Partners ↗
SERIES AOther financing Jan 2018 $39M $156M Apple Tree Partners —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Elstar Therapeutics website traffic

Latest recorded traffic for Elstar Therapeutics is 4.9K monthly website visits, up 75% over the last three months. Elstar Therapeutics's team grew 2.6% over the past year.

Latest monthly visits4.9K 3-month web change+75% 1-year team growth+2.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Hirotsu Bio ScienceDeveloped N-Nose, a non-invasive cancer screening product using nematode worms to detect early-stage cancers through urine samples Tokyo, Japan Operational 14 $196M $120M
Universal Medical Imaging DiagnosticOffers a holistic alternative and complementary approach to overall health that uses non-invasive, non-radioactive and painless imaging of the whole body Los Angeles, United States Operational
CelluminovaSpecializes in the development of new tools for stem cell research, including cancer stem cells Norrköpings kommun, Sweden Operational
CSPC Pharmaceutical GroupCSPC Pharmaceutical Group is a pharmaceutical group in China Shijiazhuang, China Operational
NuGen Medical DevicesAn emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies Toronto, Canada Operational
Skyhawk TherapeuticsA drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression Waltham, United States Operational
Onkos SurgicalSurgical oncology company that develops implants and instruments for musculoskeletal tumor patients Parsippany-Troy Hills, United States Operational
ExonateTopical small-molecule therapeutics for retinal vascular diseases Cambridge, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Elstar Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Elstar Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Apple Tree Partners
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Elstar Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Elstar Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.